Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2025 Earnings Call Transcript May 1, 2025
Blueprint Medicines Corporation misses on earnings expectations. Reported EPS is $-0.74 EPS, expectations were $-0.42.
Operator: Good morning. My name is Angela and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines 1Q 2025 Earnings Release and Conference Call. All lines have been placed on mute to prevent any background noise. After the...
